Back to Search
PETER HOPWOOD, PHARMD
PHARMD
Pharmacist
NPI: 1225917628Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
03445869(OH)
Research & Publications (20)
Health-related quality of life assessment after breast reconstruction.
PMID 19434704·Br J Surg·2009
8-other
Uptake of risk-reducing surgery in unaffected women at high risk of breast and ovarian cancer is risk, age, and time dependent.
PMID 19661091·Cancer Epidemiol Biomarkers Prev·2009
8-other
Risk reducing mastectomy: outcomes in 10 European centres.
PMID 18996907·J Med Genet·2009
4-observational
Comparison of proactive and usual approaches to offering predictive testing for BRCA1/2 mutations in unaffected relatives.
PMID 19215246·Clin Genet·2009
4-observational
The UK national breast cancer screening programme for survivors of Hodgkin lymphoma detects breast cancer at an early stage.
PMID 19672261·Br J Cancer·2009
8-other
Sequential docetaxel as adjuvant chemotherapy for early breast cancer (TACT): an open-label, phase III, randomised controlled trial.
PMID 19447249·Lancet·2009
3-trial
The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial.
PMID 18356109·Lancet Oncol·2008
4-observational
The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial.
PMID 18355913·Lancet·2008
2-rct
Preoperative chemotherapy in patients with resectable non-small cell lung cancer: results of the MRC LU22/NVALT 2/EORTC 08012 multicentre randomised trial and update of systematic review.
PMID 17544497·Lancet·2007
4-observational
The impact of age and clinical factors on quality of life in early breast cancer: an analysis of 2208 women recruited to the UK START Trial (Standardisation of Breast Radiotherapy Trial).
PMID 17236771·Breast·2007
8-other
Predictive genetic testing for BRCA1/2 in a UK clinical cohort: three-year follow-up.
PMID 17285126·Br J Cancer·2007
4-observational
Macrophage transcriptional responses following in vitro infection with a highly virulent African swine fever virus isolate.
PMID 17041222·J Virol·2006
7-preclinical
Feasibility of familial PSA screening: psychosocial issues and screening adherence.
PMID 16434991·Br J Cancer·2006
8-other
Ifosfamide, carboplatin, and etoposide with midcycle vincristine versus standard chemotherapy in patients with small-cell lung cancer and good performance status: clinical and quality-of-life results of the British Medical Research Council multicenter randomized LU21 trial.
PMID 16293867·J Clin Oncol·2005
4-observational
Epstein-Barr virus can establish infection in the absence of a classical memory B-cell population.
PMID 16103163·J Virol·2005
8-other
A randomised controlled trial of pre-operative chemotherapy followed, if feasible, by resection versus radiotherapy in patients with inoperable stage T3, N1, M0 or T1-3, N2, M0 non-small cell lung cancer.
PMID 15908042·Lung Cancer·2005
2-rct
Psychosocial aspects of risk communication and mutation testing in familial breast-ovarian cancer.
PMID 15933464·Curr Opin Oncol·2005
6-review
Surgical decisions made by 158 women with hereditary breast cancer aged <50 years.
PMID 16005602·Eur J Surg Oncol·2005
8-other
Psychosocial impact of breast/ovarian (BRCA1/2) cancer-predictive genetic testing in a UK multi-centre clinical cohort.
PMID 15505627·Br J Cancer·2004
3-trial
Breast cancer patients' experiences on endocrine therapy: monitoring with a checklist for patients on endocrine therapy (C-PET).
PMID 15454190·Breast·2004
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2500 METROHEALTH DR
CLEVELAND, OH 44109 - Phone
- (216) 778-7800
Quick Facts
- NPI
- 1225917628
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile